Patients admitted to hospital after being diagnosed with first-episode schizophrenia were comprehensively assessed prior to acute treatment (on admission), at the end of the acute treatment (at discharge), and at follow-up after 1 year. The psychopathology was evaluated using the Positive and Negative Syndrome Scale (PANSS). 93 patients were reassessed after 1 year. 73/93 (78%) of the patients fulfilled the criteria for remission. No statistically significant differences in the total PANSS or subscales scores were found between remitters and non-remitters before or after the first episode treatment. However, non-remitters had a significantly higher total PANSS score after 1 year than remitters. There was no significant difference in mean psychopathology on admission or at discharge, with the exception of items conceptual disorganization, difficulty in abstract thinking, and lack of judgment and insight between remitters and non-remitters. However, significantly higher mean values were found for all items after 1 year in non-remitters than remitters. On admission the occurrence of positive, negative and general symptoms was balanced; at discharge and after 1 year negative and general symptoms were the most frequently observed. At the 1-year follow-up the impairment of insight and judgment is one of the most frequent symptoms in both remitters (10%) and non-remitters (70%).

Department of Psychiatry Masaryk University and Faculty Hospital Brno Czech Republic

Zobrazit více v PubMed

Addington J, Leriger E, Addington D. Symptom outcome 1 year after admission to an early psychosis program. Can J Psychiatry. 2003;48:204–7. PubMed

Andreasen NC, Carpenter WT, Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9. PubMed

Arango C, Buchanan RW, Kirkpatrick B, et al. The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur Psychiatry. 2004;19:21–6. PubMed

Češková E, Přikryl R, Kašpárek T, et al. Psychopathology and treatment responsiveness of patients with first-episode schizophrenia. Neuropsychiatr Dis Treat. 2005;1:179–85. PubMed PMC

Češková E, Přikryl R, Kašpárek T, et al. Prolactin levels in risperidone treatment of first-episode schizophrenia. Int J Psych Clin Pract. 2003;8:1–6. PubMed

Kane JM, Krucht S, Carpenter D, et al. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry. 2003;64(Suppl 12):6–19. PubMed

Kay S, Fiszbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull. 1987;13:261–78. PubMed

Keshavan MS, Rabinowith J, DeSmedt G, et al. Correlates of insight in first episode psychosis. Schizophr Res. 2004;70:187–94. PubMed

Lieberman JA, Tollefson GD, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003;160:1396–404. PubMed

Malla AK, Norman RMG, Machanda R, et al. Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment. Psychiatr Serv. 2002;53:458–63. PubMed

Novak-Grubic V, Tavcar R. Treatment compliance in first-episode schizophrenia [letter] Psychiatr Serv. 1999;50:970–1. PubMed

Peralta V, Cuesta MJ, Martinez-Larrea A, et al. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am J Psychiatry. 2000;157:1461–6. PubMed

Přikryl R, Češková E, Kašpárek T, et al. Neurological soft sings, clinical symptoms and treatment reactivity in patiens suffering from first episode schizophrenia. J Psych Res. 2006;40:141–6. PubMed

Robinson DG, Woerner MG, Alvir JMJ, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 1999;156:544–49. PubMed

Scottish Schizohrenia Research Group. The Scottish first episode schizophrenia study. Br J Psychiatry. 1987;150:334–8. PubMed

Verdoux H, Lengronne J, Liraud F, et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand. 2000;102:203–10. PubMed

Brain functional connectivity of male patients in remission after the first episode of schizophrenia